Clinical trial
Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid…
NCT00038883 · M.D. Anderson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00038883 |
|---|---|
| Title | Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies |
| Official title | Campath-1H Snd Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Leudosite |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Leukemia, Lymphocytic, Chronic, Acute, Lymphoma, Low-Grade, T-Cell, B-Cell |
| Intervention type | Drug |
| Interventions | Campath-1H |
| Enrollment | 19 |
| Start date | Apr 9, 2001 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Jun 7, 2002 |
| Last update posted | Nov 7, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: